Vaccinex, Inc. - Altered myeloid and lymphoid composition of tumor microenvironment following anti-SEMA4D and immune checkpoint combination therapies

Monday, April 1, 2019 8:00 a.m. ET  

Supporting Materials

Title
Vaccinex, Inc. - Altered myeloid and lymphoid composition of tumor microenvironment following anti-SEMA4D and immune checkpoint combination therapies
Date / Time
04/01/19 8:00 a.m. ET